You're reading the free version. Trader adds the live tape and alerts.
Start tracking
VRTX Sale Disclosure
Tatsis Ourania · SEC Form 4 · Filed Jul 7, 2026
Sale
Calculated transaction value
$787.49K
Tatsis Ourania EVP, Chief Reg. & Quality Off.
VRTX
Transaction date
Jul 2, 2026
Public filing date
Jul 7, 2026
Filing lag
Filed 5 days later
VRTX daily price context
Close on/before transaction
$528.04
Jul 2, 2026
First close after public filing
$498.43
Jul 8, 2026
30-day return after filing
-2.89%
Through Aug 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,500 shares @ $524.99
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000875320-26-000245
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$787.49K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vertex Pharmaceuticals Inc / Ma VRTX Current | Sale | Jul 2, 2026 | $787.49K |